Recent News

• 12.15.2025 - Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
• 12.01.2025 - Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
• 11.12.2025 - Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

Recent Filings

• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 8-K Current report
• 11.12.2025 - EX-99.1 EX-99.1
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.07.2025 - 8-K Current report
• 10.07.2025 - EX-99.1 EX-99.1
• 09.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2025 - 8-K Current report
• 08.19.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 8-K Current report